Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer
In an international, multicenter Phase II clinical trial led by The University of Texas MD Anderson Cancer Center, 63.3% of patients with stage II–IV cutaneous squamous cell carcinoma (CSCC) saw their tumors nearly or completely ...
Sep 12, 2022
0
6